Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SiderAL Forte is a branded dietary supplement designed to address iron deficiency and anemia. Its key active ingredient is Sucrosomial Iron (iron pyrophosphate encapsulated in a matrix of phospholipids and sucrose esters), which enhances intestinal absorption while minimizing common gastrointestinal side effects associated with traditional iron supplements. The formulation also includes vitamin C, which further improves iron absorption and supports immune function, energy metabolism, cognitive performance, and the reduction of fatigue. Some formulations may also contain vitamin B12. The product is intended for individuals with increased nutritional needs or dietary deficiencies of iron and can be used for extended periods[1][2][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SiderAL Forte.